Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Total Non-Current Liabilities: 2019-2025

Historic Total Non-Current Liabilities for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $338.4 million.

  • Beam Therapeutics' Total Non-Current Liabilities fell 9.71% to $338.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $338.4 million, marking a year-over-year decrease of 9.71%. This contributed to the annual value of $364.9 million for FY2024, which is 23.29% down from last year.
  • As of Q3 2025, Beam Therapeutics' Total Non-Current Liabilities stood at $338.4 million, which was up 0.16% from $337.8 million recorded in Q2 2025.
  • Over the past 5 years, Beam Therapeutics' Total Non-Current Liabilities peaked at $616.3 million during Q4 2021, and registered a low of $234.0 million during Q1 2021.
  • Its 3-year average for Total Non-Current Liabilities is $425.0 million, with a median of $406.1 million in 2024.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 346.52% in 2021, then fell by 26.08% in 2024.
  • Over the past 5 years, Beam Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $616.3 million in 2021, then dropped by 3.34% to $595.8 million in 2022, then declined by 20.16% to $475.7 million in 2023, then decreased by 23.29% to $364.9 million in 2024, then declined by 9.71% to $338.4 million in 2025.
  • Its Total Non-Current Liabilities was $338.4 million in Q3 2025, compared to $337.8 million in Q2 2025 and $337.4 million in Q1 2025.